tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmidt, 171 are a BUY (79.91%), 43 are a HOLD (20.09%).
Analyst Michael Schmidt, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 53.47% that have a potential upside of 44.82% achieved within 254 days.
Michael Schmidt’s has documented 442 price targets and ratings displayed on 53 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on RVMD, Revolution Medicines at 20-Jan-2026.
Analyst best performing recommendations are on IONS (IONIS PHARMACEUTICALS).
The best stock recommendation documented was for IONS (IONIS PHARMACEUTICALS) at 7/14/2016. The price target of $26 was fulfilled within 1 day with a profit of $1.48 (6.04%) receiving and performance score of 60.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Jun-2022
$4
3 years 7 months 16 days ago
(14-Jun-2022)
0/11 (0%)
$2.53 (172.11%)
Hold Since 30-Oct-2018
$4.75
$4.66 (5177.78%)
$5.75
4 years 2 months 27 days ago
(03-Nov-2021)
10/12 (83.33%)
$0.06 (1.28%)
65
Sell Since 27-Apr-2020
5 years 2 months 24 days ago
(06-Nov-2020)
3/5 (60%)
$5.73 (134.19%)
42
Buy Since 09-May-2018
$16
$15.91 (17677.78%)
$17
5 years 5 months 23 days ago
(07-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
77
Sell Since 08-Oct-2019
$4
$3.91 (4344.44%)
$3
5 years 8 months 24 days ago
(06-May-2020)
3/5 (60%)
$-4.07 (-50.43%)
191
Which stock is Michael Schmidt is most bullish on?
Which stock is Michael Schmidt is most reserved on?
What Year was the first public recommendation made by Michael Schmidt?
